eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | non-alcoholic fatty liver disease |
| Symptom | C0427008|stiffness |
| Sentences | 5 |
| PubMedID- 22651911 | Effects of increased systemic inflammation and central obesity on arterial stiffness in patients with nonalcoholic fatty liver disease. |
| PubMedID- 22676459 | We have previously reported that 4 months metformin treatment was associated with a significant improvement in arterial stiffness in patients with nonalcoholic fatty liver disease 7. |
| PubMedID- 21256907 | Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease. |
| PubMedID- 24308370 | Metformin treatment was for example shown to improve endothelium-dependent vasodilation and microvascular reactivity in humans with the metabolic syndrome , and to improve arterial stiffness in patients with nonalcoholic fatty liver disease, which was partly explained by an increase in circulating adiponectin levels . |
| PubMedID- 25991038 | The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease. |
Page: 1